Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | UMF554N5FG |
InChI Key | VAZAPHZUAVEOMC-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C15H15N3O2 |
Molecular Weight | 269.3 |
AlogP | 2.48 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 84.22 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 20.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Histone deacetylase inhibitor | PubMed |
Primary Target | |
---|---|
histone deacetylase 1 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class I
|
3810 | 41-18220 | - | 190 | 42-81 | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIa
|
3810 | 1810-6000 | - | - | 42-81 | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
3810 | 1810-6000 | - | - | 42-81 | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IV
|
3810 | 1810-6000 | - | - | 42-81 | |
Unclassified protein
|
- | 190 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Lung Neoplasms | 3 | D008175 | ClinicalTrials |
Multiple Myeloma | 2 | D009101 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 112522-64-2 |
ChEBI | 90195 |
ChEMBL | CHEMBL235191 |
DrugBank | DB12291 |
EPA CompTox | DTXSID60150095 |
FDA SRS | UMF554N5FG |
Guide to Pharmacology | 8367 |
PubChem | 2746 |
SureChEMBL | SCHEMBL144794 |
ZINC | ZINC000000003803 |